<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Document</title>
    <link rel="stylesheet" href="biosplice.css">
</head>

<body>
    <header>
        <div class="first">
            <p class="logo">biosplice</p>
            <div class="bar"><img
                    src="https://as1.ftcdn.net/v2/jpg/01/94/08/90/1000_F_194089022_s5bRp5EBUmBTUvs05XMPaqmZwCiyYuyG.jpg"
                    alt=""></div>

        </div>

        <nav>
            <a href="">About</a>
            <a href=""> Studies</a>
            <a href="">Publications</a>
            <a href=""> Development</a>
            <a href="">News</a>
            <a href="">Careers</a>
        </nav>
    </header>
    <section>
        <div class="text">
            <p class="sec">Our mission is to restore <br>health by delivering first-in- <br>class therapies that harness
                <br>alternative splicing</p>
        </div>
        <div class="pic"><img src="https://www.biosplice.com/_assets/img/home/banner/01.jpg" alt=""></div>
    </section>

    <div class="content">
        <div class="half">
            <div>
            <p class="heading">What is Alternative Splicing? </p>
                In human DNA, approximately 20,000 genes code for hundreds of thousands of distinct proteins required
                for normal tissue development and function. This is possible because a single gene can translate into
                multiple protein variants, with distinct and sometimes opposing function, through a dynamic and heavily
                regulated mechanism known as alternative pre-mRNA splicing, commonly known as alternative splicing.</p>
                </div>
        </div>
        <div class="half">
            <div>
                <p class="heading">Alternative pre-mRNA Splicing and Disease</p>
                Alternative splicing regulates genome potential by differentially joining or skipping gene segments at alternative splice sites. The resulting proteome diversification is a fundamental physiological aspect of tissue fate and function. Conversely, dysregulated alternative splicing can be a root cause of developmental disorders, tissue degeneration and cancer.
            </div>
        </div>
    </div>
    <div class="footer">
        <p>Privacy Policy</p>
        <p>Terms of Use</p>
        <p>Contact Us</p>
        <p>Â© Biosplice Therapeutics, Inc. All rights reserved.</p>
    </div>


</body>

</html>